During our recent trip to Washington D.C. Every Cure announced its $48.3M contract with ARPA-H at the White House. During Co-Founder’s Dr. David Fajgenbaum’s remarks he spoke about the development of an innovative AI-driven platform called MATRIX designed to revolutionize the field of drug repurposing, offering new hope in the treatment of underserved diseases.
While in DC, we also met with key government leaders, including current FDA Commissioner Rob Califf (left) and Francis Collins (right), the former Director of the National Institute of Health. It’s important for us to work with government agencies to ensure the regulatory process is smooth for approvals for these discoveries to actually reach patients. We called ourselves Every Cure because we want to work with every entity across government, private industry and also public organizations to make sure that we unlock every drug’s full potential.
Co-Founder Dr. David Fajgenbaum also addressed the ARPA-H team at their headquarters in Washington D.C. about Every Cure’s origin story and our mission to unlock the full potential of existing medicines to treat every disease and every patient they possibly can.